UTMD
Utah Medical Products, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+42/100
Last price
73.83
▲ 0.52 (0.71%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
73.80
Prev close
73.31
Day high
74.15
Day low
73.71
Volume
63.03K
Market cap
$234.32M
P/E (TTM)
22.37
52W range
53.66 – 76.89
Day trading desk
Gap from prior close
+0.67%
Prior close 73.31
VWAP
73.90
-0.09% from price
Relative volume
3.52×
Unusually busy
Session range
0.88%
73.50 – 74.14
Position in range
51%
Mid range
ATR (14D)
0.99
1.35% of price
Prior day high
74.28
PDH
Prior day low
73.22
PDL
Bid / ask spread
—
Quote not published
Session volume
117.41K
Avg 33.40K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.49%
-3.4%
1M
+3.84%
+2.7%
3M
+8.48%
+4.0%
6M
+16.32%
-1.9%
YTD
+31.93%
+17.7%
1Y
+16.64%
+0.2%
3Y
-14.15%
-96.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on UTMD open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
228.57K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 29, 26 | RICHINS PAUL O Director |
STOCK | 150 | $10.96K | Indirect |
| May 28, 26 | KOOPMAN BRIAN L. Officer |
STOCK | 50 | $3.31K | Direct |
| Sep 4, 25 | KOOPMAN BRIAN L. Officer |
STOCK | 50 | $3.14K | Direct |
| Aug 25, 25 | RICHINS PAUL O Director |
STOCK | 100 | $6.03K | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
KOOPMAN BRIAN L. |
Officer | 782 | Stock Gift |
RICHINS PAUL O |
Director | — | Stock Gift |
Fundamentals
Market cap$234.32M
Enterprise value$147.73M
Revenue (TTM)$36.11M
Gross profit$20.91M
EBITDA$14.37M
Net income$10.49M
EPS (TTM)$3.30
Free cash flow$8.84M
Total cash$87.53M
Total debt$195.00K
Book value / share$38.34
Shares outstanding3.17M
Float2.78M
Short % of float6.64%
Dividend yield1.69%
Beta (5Y)0.39
Valuation & profitability ratios
Trailing P/E22.37
Forward P/E—
PEG ratio4.25
Price / sales—
Price / book1.93
EV / revenue4.09
EV / EBITDA10.28
Gross margin57.90%
Operating margin36.89%
Profit margin29.04%
Return on equity8.76%
Return on assets6.10%
Debt / equity0.16
Current ratio48.62
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $38.52M | $40.90M | $50.22M | $52.28M | -5.8% |
| Operating revenue | $38.52M | $40.90M | $50.22M | $52.28M | -5.8% |
| Cost of revenue | $16.52M | $16.76M | $20.19M | $20.09M | -1.4% |
| Gross profit | $22.00M | $24.14M | $30.04M | $32.20M | -8.9% |
| Research & development | $668.00K | $813.00K | $560.00K | $493.00K | -17.8% |
| Selling, general & admin | $9.93M | $9.74M | $12.70M | $11.91M | +2.0% |
| Total operating expense | $10.60M | $10.55M | $13.26M | $12.41M | +0.5% |
| Operating income | $11.40M | $13.59M | $16.78M | $19.79M | -16.1% |
| Pre-tax income | $14.11M | $16.80M | $20.09M | $20.66M | -16.0% |
| Tax provision | $2.82M | $2.93M | $3.45M | $4.19M | -3.6% |
| Net income | $11.29M | $13.87M | $16.64M | $16.47M | -18.7% |
| Net income to common | $11.29M | $13.87M | $16.64M | $16.47M | -18.7% |
| Basic EPS | 3.54 | 4.16 | 4.58 | 5.69 | -14.9% |
| Diluted EPS | 3.48 | 3.96 | 4.57 | 4.52 | -12.1% |
| EBIT | $11.40M | $13.59M | $16.78M | $19.79M | -16.1% |
| EBITDA | $14.41M | $16.44M | $23.14M | $26.87M | -12.3% |
| Basic shares | 3.19M | 3.34M | 3.63M | 3.63M | -4.5% |
| Diluted shares | 3.24M | 3.50M | 3.64M | 3.64M | -7.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $85.76M | $82.98M | $92.87M | $75.05M | +3.4% |
| Cash & short-term investments | $85.76M | $82.98M | $92.87M | $75.05M | +3.4% |
| Accounts receivable | $4.04M | $4.24M | $3.49M | $5.54M | -4.8% |
| Inventory | $7.93M | $8.81M | $9.58M | $8.81M | -10.0% |
| Total current assets | $97.74M | $96.33M | $106.27M | $89.92M | +1.5% |
| Property, plant & equipment | $9.91M | $9.76M | $10.55M | $10.22M | +1.5% |
| Goodwill & intangibles | $14.89M | $16.45M | $18.64M | $23.73M | -9.4% |
| Total assets | $122.54M | $122.54M | $135.46M | $123.87M | +0.0% |
| Total current liabilities | $2.60M | $3.76M | $4.71M | $5.96M | -30.8% |
| Total debt | $225.00K | $282.00K | $295.00K | $341.00K | -20.2% |
| Total liabilities | $3.27M | $5.11M | $7.14M | $9.62M | -35.9% |
| Retained earnings | $128.65M | $129.30M | $138.34M | $126.01M | -0.5% |
| Shareholder equity | $119.27M | $117.43M | $128.31M | $114.25M | +1.6% |
| Working capital | $95.14M | $92.57M | $101.56M | $83.96M | +2.8% |
| Net tangible assets | $104.38M | $100.98M | $109.67M | $90.52M | +3.4% |
| Shares issued | 3.19M | 3.34M | 3.63M | 3.63M | -4.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $11.29M | $13.87M | $16.64M | $16.47M | -18.7% |
| Depreciation & amortisation | $3.01M | $2.85M | $6.37M | $7.08M | +5.7% |
| Stock-based compensation | $373.00K | $256.00K | $225.00K | $183.00K | +45.7% |
| Change in working capital | $317.00K | -$1.80M | -$233.00K | -$2.23M | +117.6% |
| Operating cash flow | $14.69M | $14.83M | $22.28M | $21.15M | -0.9% |
| Capital expenditure | -$371.00K | -$235.00K | -$639.00K | -$818.00K | -57.9% |
| Investing cash flow | -$371.00K | -$208.00K | -$639.00K | -$818.00K | -78.4% |
| Share buybacks | -$8.36M | -$19.97M | $0 | -$2.50M | +58.2% |
| Dividends paid | -$3.98M | -$4.26M | -$4.28M | -$3.16M | +6.5% |
| Financing cash flow | -$12.34M | -$23.84M | -$4.17M | -$5.48M | +48.2% |
| Free cash flow | $14.32M | $14.60M | $21.64M | $20.33M | -1.9% |
| End cash position | $85.76M | $82.98M | $92.87M | $75.05M | +3.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $8.53M | $8.72M | $9.04M | $9.81M | $9.95M | -2.2% |
| Operating revenue | $8.53M | $8.72M | $9.04M | $9.81M | $9.95M | -2.2% |
| Cost of revenue | $3.77M | $3.44M | $3.78M | $4.21M | $4.36M | +9.6% |
| Gross profit | $4.76M | $5.28M | $5.26M | $5.60M | $5.59M | -9.9% |
| Research & development | $154.00K | $154.00K | $212.00K | $167.00K | $135.00K | 0.0% |
| Selling, general & admin | $1.96M | $1.66M | $2.61M | $2.83M | $2.26M | +17.5% |
| Total operating expense | $2.11M | $2.28M | $2.82M | $2.99M | $2.40M | -7.3% |
| Operating income | $2.65M | $3.01M | $2.44M | $2.61M | $3.20M | -11.9% |
| Pre-tax income | $3.29M | $3.18M | $3.11M | $3.31M | $3.84M | +3.3% |
| Tax provision | $600.00K | $578.00K | $540.00K | $678.00K | $788.00K | +3.8% |
| Net income | $2.69M | $2.60M | $2.57M | $2.63M | $3.05M | +3.1% |
| Net income to common | $2.69M | $2.60M | $2.57M | $2.63M | $3.05M | +3.1% |
| Basic EPS | 0.84 | 0.82 | 0.81 | 0.82 | 0.94 | +3.2% |
| Diluted EPS | 0.84 | 0.82 | 0.80 | 0.82 | 0.94 | +3.2% |
| EBIT | $2.65M | $3.01M | $2.44M | $2.61M | $3.20M | -11.9% |
| EBITDA | $2.89M | $3.69M | $3.20M | $3.38M | $3.95M | -21.8% |
| Basic shares | 3.18M | 3.18M | 3.19M | 3.21M | 3.25M | -0.0% |
| Diluted shares | 3.18M | 3.18M | 3.20M | 3.21M | 3.25M | -0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $87.53M | $87.41M | $85.76M | $84.27M | $82.18M | +0.1% |
| Cash & short-term investments | $87.53M | $87.41M | $85.76M | $84.27M | $82.18M | +0.1% |
| Accounts receivable | $3.56M | $3.64M | $4.04M | $3.73M | $3.63M | -2.0% |
| Inventory | $9.00M | $8.72M | $7.93M | $8.12M | $8.23M | +3.2% |
| Total current assets | $100.64M | $100.38M | $97.74M | $96.53M | $94.38M | +0.3% |
| Property, plant & equipment | $9.63M | $9.72M | $9.91M | $10.00M | $10.26M | -0.9% |
| Goodwill & intangibles | $14.30M | $14.28M | $14.89M | $15.44M | $16.17M | +0.1% |
| Total assets | $124.57M | $124.38M | $122.54M | $121.97M | $120.80M | +0.2% |
| Total current liabilities | $2.07M | $3.50M | $2.60M | $3.01M | $2.25M | -40.9% |
| Total debt | $195.00K | $210.00K | $225.00K | $241.00K | $256.00K | -7.1% |
| Total liabilities | $2.54M | $4.01M | $3.27M | $3.72M | $3.27M | -36.7% |
| Retained earnings | $131.95M | $130.26M | $128.65M | $127.96M | $126.86M | +1.3% |
| Shareholder equity | $122.03M | $120.37M | $119.27M | $118.25M | $117.53M | +1.4% |
| Working capital | $98.57M | $96.87M | $95.14M | $93.52M | $92.12M | +1.8% |
| Net tangible assets | $107.73M | $106.09M | $104.38M | $102.81M | $101.36M | +1.5% |
| Shares issued | 3.18M | 3.18M | 3.19M | 3.20M | 3.22M | -0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $2.69M | $2.60M | $2.57M | $2.63M | $3.05M | +3.1% |
| Depreciation & amortisation | $241.00K | $688.00K | $760.00K | $769.00K | $758.00K | -65.0% |
| Stock-based compensation | $72.00K | $120.00K | $111.00K | $94.00K | $86.00K | -40.0% |
| Change in working capital | -$1.59M | -$141.00K | $86.00K | $263.00K | -$870.00K | -1,026.2% |
| Operating cash flow | $1.38M | $3.11M | $3.48M | $3.88M | $2.87M | -55.5% |
| Capital expenditure | -$134.00K | -$130.00K | -$109.00K | -$27.00K | -$51.00K | -3.1% |
| Investing cash flow | -$134.00K | -$130.00K | -$109.00K | -$27.00K | -$51.00K | -3.1% |
| Share buybacks | -$78.00K | -$128.00K | -$994.00K | -$653.00K | -$3.49M | +39.1% |
| Dividends paid | -$987.00K | -$989.00K | -$977.00K | -$988.00K | -$1.00M | +0.2% |
| Financing cash flow | -$1.06M | -$1.12M | -$1.97M | -$1.64M | -$4.49M | +4.7% |
| Free cash flow | $1.25M | $2.98M | $3.37M | $3.85M | $2.82M | -58.1% |
| End cash position | $87.53M | $87.41M | $85.76M | $84.27M | $82.18M | +0.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders7.18%
Held by institutions76.55%
Institutions holding169
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
74.30
-0.64% from price
SMA 20
73.54
+0.40% from price
SMA 50
72.18
+2.28% from price
SMA 100
69.95
+5.55% from price
SMA 200
66.65
+10.77% from price
EMA 12
73.96
-0.18% from price
EMA 26
73.28
+0.75% from price
EMA 50
72.20
+2.26% from price
RSI (14)
53.1
Neutral
MACD (12,26,9)
0.68
Hist -0.16
ATR (14)
0.99
1.35% of price
Realised vol 30D
24.4%
Annualised
Bollinger upper
77.38
20, 2σ
Bollinger lower
69.70
20, 2σ
50 / 200 cross
Golden
72.18 vs 66.65
Trend bias
Above 200
+10.77%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.25
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
24.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-15.2%
Peak to trough
Max drawdown 5Y
-58.5%
Peak to trough
ATR 14
0.99
1.35% of price
Beta (reported)
0.39
5Y monthly, from filing
Short interest
Shares short
172.18K
Prior 139.72K
Change vs prior
+23.2%
Shorts adding
% of float
6.64%
Normal
% of shares out
5.43%
Against total outstanding
Days to cover
4.3
Liquid
Float
2.78M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Dividends & splits
Forward rate$1.24 / yr
Forward yield1.69%
5-year avg yield1.49%
Payout ratio37.65%
Ex-dividend dateSep 17, 2026
Next pay dateOct 5, 2026
Last split—
Split date—
SEC filings
Tender Offer/Acquisition Reports
SC TO-I/A · 2026-10-05
Tender Offer/Acquisition Reports
SC TO-I/A · 2026-09-29
Tender Offer/Acquisition Reports
SC TO-C · 2026-09-25
Tender Offer/Acquisition Reports
SC TO-I · 2026-09-24
Tender Offer/Acquisition Reports
SC TO-C · 2026-09-17
Corporate Changes & Voting Matters
8-K · 2026-08-31
Periodic Financial Reports
10-Q · 2026-08-12
Corporate Changes & Voting Matters
8-K · 2026-07-23
Headlines
Utah Medical Products, Inc. Extends Tender Offer
ACCESS Newswire · 2d ago
Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date
ACCESS Newswire · 12d ago
Utah Medical Launches Tender Offer
MT Newswires · 12d ago
Utah Medical Products, Inc. Commences Tender Offer
ACCESS Newswire · 12d ago
Utah Medical Products Inc's Dividend Analysis
GuruFocus.com · 20d ago
UTMD Announces Self-Tender for 20% of Its Shares
ACCESS Newswire · 22d ago
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
ACCESS Newswire · 37d ago
Utah Medical Products, Inc. Announces Quarterly Dividend
ACCESS Newswire · 64d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.